# Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease

> **NCT00609973** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 33 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00609973
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609973, "Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00609973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*